Clinical trial
Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-Assessment
NCT06381284 is registered in ClinicalTrials.gov with ZS Associates as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-Assessment
- Lead sponsor
- ZS Associates
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 28, 2024
- Completion date
- March 3, 2025
- Enrollment
- 215 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.